ClexBio is a pre-clinical stage regenerative medicine company with a breakthrough platform for scalable, high-throughput generation of therapeutic tissues. We represent the next generation of cell therapy, leveraging fully functional bioengineered tissues to elevate the restorative ability of cells and produce a new class of curative treatments for some of the world’s most challenging medical conditions